tiprankstipranks
Trending News
More News >
Day One Biopharmaceuticals (DAWN)
NASDAQ:DAWN
US Market
Advertisement

Day One Biopharmaceuticals (DAWN) Financial Statements

Compare
364 Followers

Day One Biopharmaceuticals Financial Overview

Day One Biopharmaceuticals's market cap is currently $765.17M. The company's EPS TTM is $-0.29; its P/E ratio is ―; Day One Biopharmaceuticals is scheduled to report earnings on August 5, 2025, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Day One Biopharmaceuticals Earnings and Revenue History

Day One Biopharmaceuticals Debt to Assets

Day One Biopharmaceuticals Cash Flow

Day One Biopharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis